Analyst Consensus ?
ConsensusHold49 ratings
Bullish2347.0%
Neutral2346.9%
Bearish36.1%
FN2 Earnings Intelligence
Huntington Bancshares Incorporated complete analyst coverage
Huntington Bancshares Incorporated (HBAN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$15.65Current
$14.5Low
$18.53Average
$23High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Oct 26, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 23, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 6, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| DA Davidson | Buy | Buy | Maintain | Sep 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 18, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 18, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Jul 27, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jul 24, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jul 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jan 5, 2026 |
| Piper Sandler | Underweight | Underweight | Maintain | Dec 10, 2025 |
| TD Cowen | Buy | Buy | Maintain | Oct 20, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 20, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 3, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 26, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 24, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 6, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 25, 2019 |
| Macquarie | Underperform | Neutral | Downgrade | Jul 12, 2019 |
| Argus | Hold | Hold | Maintain | May 31, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Nov 29, 2018 |
| Hilliard Lyons | Buy | Neutral | Upgrade | Feb 9, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| JMP Securities | Perform | Market Perform | Maintain | Aug 31, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Aug 11, 2017 |
| FBR Capital | Market Perform | Outperform | Downgrade | Oct 11, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 6, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| CLSA | Underperform | Underperform | Maintain | Jul 8, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| Canaccord Genuity | Hold | Buy | Downgrade | May 11, 2015 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Apr 24, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Mar 9, 2015 |
| Portales Partners | Sector Perform | Underperform | Upgrade | Jul 21, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Oct 7, 2013 |
| Compass Point | Neutral | Buy | Downgrade | Apr 18, 2013 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | May 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $15.66. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Analyst unavailable | $19 | $15.66 | +21.4% | Oct 23, 2026 |
| Wells Fargo | Analyst unavailable | $19 | $15.66 | +21.4% | Oct 23, 2026 |
| UBS | Analyst unavailable | $18 | $15.36 | +15.0% | Oct 6, 2026 |
| UBS | Erika Najarian | $19 | $15.33 | +21.4% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $19 | $15.69 | +21.4% | Sep 23, 2026 |
| D.A. Davidson | Peter Winter | $20 | $15.94 | +27.8% | Sep 21, 2026 |
| Wells Fargo | Analyst unavailable | $21 | $15.93 | +34.1% | Sep 16, 2026 |
| Wells Fargo | Mike Mayo | $23 | $17.91 | +46.9% | Aug 17, 2026 |
| Truist Financial | Analyst unavailable | $20 | $17.24 | +27.8% | Jul 28, 2026 |
| Robert W. Baird | David George | $21 | $17.4 | +34.1% | Jul 24, 2026 |
| Stephens | Analyst unavailable | $19 | $17.4 | +21.4% | Jul 24, 2026 |
| Jefferies | Analyst unavailable | $18 | $17.4 | +15.0% | Jul 23, 2026 |
| UBS | Analyst unavailable | $22 | $18.03 | +40.5% | Jul 7, 2026 |
| Evercore ISI | John Pancari | $21 | $17.76 | +34.1% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $19 | $17.86 | +21.4% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $21 | $17.81 | +34.1% | Jun 29, 2026 |
| Evercore ISI | Analyst unavailable | $20 | $17.21 | +27.8% | Jun 12, 2026 |
| Piper Sandler | Analyst unavailable | $18 | $16.62 | +15.0% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $20 | $16.12 | +27.8% | Mar 9, 2026 |
| UBS | Analyst unavailable | $21 | $19.08 | +34.1% | Feb 4, 2026 |
| National Bank | Manan Gosalia | $21 | $18.39 | +34.1% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $21 | $17.8 | +34.1% | Jan 12, 2026 |
| Wolfe Research | Analyst unavailable | $21 | $18.1 | +34.1% | Jan 7, 2026 |
| Goldman Sachs | Ryan Nash | $21 | $17.99 | +34.1% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $20 | $17.48 | +27.8% | Jan 5, 2026 |
| RBC Capital | Analyst unavailable | $20 | $17.62 | +27.8% | Dec 19, 2025 |
| Piper Sandler | Analyst unavailable | $16 | $17 | +2.2% | Dec 10, 2025 |
| Evercore ISI | John Pancari | $18 | $15.97 | +15.0% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $23 | $17.42 | +46.9% | Sep 29, 2025 |
| Argus Research | Kevin Heal | $17 | $14.46 | +8.6% | Apr 25, 2025 |
| Truist Financial | Brian Foran | $21 | $16.55 | +34.1% | Jan 21, 2025 |
| Citigroup | Keith Horowitz | $18 | $15.36 | +15.0% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $15 | $15.43 | -4.2% | Oct 18, 2024 |
| Morgan Stanley | Manan Gosalia | $18 | $13.75 | +15.0% | Aug 5, 2024 |
| Robert W. Baird | David George | $15 | $15.06 | -4.2% | Jul 26, 2024 |
| Argus Research | Kevin Heal | $16 | $15.01 | +2.2% | Jul 22, 2024 |
| RBC Capital | Jon Arfstrom | $17 | $14.86 | +8.6% | Jul 22, 2024 |
| Morgan Stanley | Manan Gosalia | $16 | $14.8 | +2.2% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $17.5 | $15.01 | +11.8% | Jul 22, 2024 |
| Stephens | Terry McEvoy | $16 | $15.01 | +2.2% | Jul 22, 2024 |
| Piper Sandler | Scott Siefers | $11.5 | $12.34 | -26.5% | Jun 14, 2024 |
| Piper Sandler | Scott Siefers | $13.5 | $12.77 | -13.8% | Jun 10, 2024 |
| Jefferies | Ken Usdin | $16 | $13.6 | +2.2% | Apr 8, 2024 |
| Stephens | Terry McEvoy | $15 | $13.95 | -4.2% | Apr 1, 2024 |
| UBS | Erika Naharian | $15 | $12.72 | -4.2% | Feb 14, 2024 |
| D.A. Davidson | Analyst unavailable | $15 | $14 | -4.2% | Dec 21, 2022 |
| J.P. Morgan | Analyst unavailable | $14.5 | $14.54 | -7.4% | Dec 13, 2022 |
| Morgan Stanley | Analyst unavailable | $19 | $15.46 | +21.4% | Dec 5, 2022 |
| Raymond James | Analyst unavailable | $18 | $14.1 | +15.0% | Apr 22, 2022 |
| RBC Capital | Jon Arfstrom | $19 | $15.03 | +21.4% | Jan 21, 2022 |
| Barclays | Jason Goldberg | $17 | $15.64 | +8.6% | Jan 3, 2022 |
| Stephens | Terry McEvoy | $17.5 | $15.55 | +11.8% | Nov 9, 2021 |
| Goldman Sachs | Ryan Nash | $18 | $14.27 | +15.0% | Aug 18, 2021 |
| KBW | David Konrad | $15 | $13.56 | -4.2% | Jul 6, 2021 |
Track every rating change on HBAN the moment it posts. Free to start.
Start freeGet the HBAN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.